Since JAK/STAT pathways are involved in a number of inflammatory diseases, there is an abundance of research focusing on the modulation of KIR actions in models of diabetes, atherosclerosis, EAE, and dermatological diseases [33,62]. The gene discussed is SOAT1; the disease is diabetes mellitus.